Skip to main content
. 2024 May 20;10(1):FSO942. doi: 10.2144/fsoa-2023-0119

Table 1.

Case reports of intestinal T-cell lymphomas not otherwise specified.

Case Age Gender Complication Location Treatment Survival
1(12) 67 Male Perforation Small bowel Surgery followed by chemotherapy 15 months
2(12) 65 Male No Small bowel Palliative care only 13 months
3(13) 55 Male Perforation Small bowel CHOP  
4(14) 73 Female Perforation Duodenum Surgery <2 months
Our case 87 Female No Colon Palliative care 40 days

CHOP: Cyclophosphamide, doxorubicin hydrochloride [hydroxydaunorubicin], vincristine sulfate [Oncovin®] and prednisone.